Strategic vs. Private Equity Buyers: Who Is the Right Partner for Your Pharma Services Company?
Companies across the clinical research ecosystem, including CROs, clinical research sites and site networks, site management organizations (SMOs), and patient recruitment and enrollment providers, continue to attract significant interest from both strategic acquirers and private equity investors. As clinical trial volume grows and the need for efficient patient access intensifies, well operated research organizations have […]
Objective Valuation Advisory Expands Nationally Under New Leadership
Jordi Pujol, CFA appointed to lead Objective’s Valuation Advisory Group, driving nationwide growth and strengthening partnerships with financial and M&A professionals across the U.S. LOS ANGELES, November 06, 2025–(BUSINESS WIRE)–Objective, Investment Banking & Valuation (“Objective”), a leading middle-market investment banking and valuation firm, today announced the national expansion of its Valuation Advisory Group under the […]
When Unsolicited Interest Comes Knocking: How ConTech SaaS Founders Should Respond
The Rise of Unsolicited Offers in ConTech SaaS If you’re a ConTech SaaS founder, you’re already seeing it: unsolicited emails from strategics and private equity buyers who “just want to have a conversation.” These aren’t random. The built environment is digitizing fast, and your platform’s data, integrations, or user stickiness may fill a strategic gap in a buyer’s product roadmap. But […]
Technology Industry Report | H1 2025
The Great Tech Rebound: AI, Cybersecurity, and Vertical SaaS Redefine Software M&A In this Technology M&A Industry Report, we explore the M&A activity from H1 2025 across our select areas of expertise within the Technology industry. Our Technology Practice Group experts share their insights on the current state of the Tech M&A market and look […]
Objective Advises ANA Global in Sale to Gainline, Unlocking Cost and Supply Chain Advantages Through Mexico Operations
Strategic Acquisition of ANA Global Highlights Growing Nearshoring Opportunities for Manufacturers San Diego, CA – October 14, 2025 – Objective, Investment Banking & Valuation (“Objective”), an award-winning middle-market investment banking and valuation firm, is pleased to announce that it served as the exclusive sell-side advisor to ANA Global, LLC (“ANA” or the “Company”), a leading […]
How to Sell a Precision Manufacturing Business (Plastics, Metals & Components)
Precision manufacturing businesses, particularly those producing plastics, metals, and engineered components, remain at the center of strategic investment and consolidation. Over the past twelve months, despite uneven macroeconomic conditions, mergers and acquisitions activity in this segment of the U.S. manufacturing market has proven resilient. Recent landmark transactions, including Amcor’s $8.4 billion merger with Berry Global […]
Valuation of Clinical Research Sites: What Buyers Look For in a Clinical Research Site Company
The clinical research site (CRS) sector has become one of the most active areas in life sciences M&A. With pharmaceutical companies accelerating development pipelines and competition for experienced trial sites intensifying, clinical research site businesses are increasingly viewed as strategic assets. For owners and operators, understanding the dynamics that influence valuation is essential to positioning […]
What Acquirers Are Looking for in ERP SaaS and Why Retention and Vertical AI Define “Choice Assets”
Enterprise Resource Planning (ERP) SaaS platforms are deeply embedded in customers’ operations, making them highly attractive in M&A. But what separates good assets from choice assets in today’s market? Buyers are converging on two differentiators: Customer retention – proof that the platform is sticky, mission-critical, and capable of expansion. Vertical-specific generative AI enablement – evidence […]
Objective, Investment Banking & Valuation Named Finalists for 24th Annual M&A Advisor Awards
Los Angeles, CA – September 26, 2025 – Objective, Investment Banking & Valuation is honored to announce that we have been named finalists in seven prestigious categories for the 24th Annual M&A Advisor Awards. These nominations underscore our dedication to delivering exceptional outcomes for our clients and our commitment to excellence in the mergers and […]
How to Sell a Contract Research Organization (CRO): A Strategic Guide for Founders
For founders of contract research organizations (CROs), pursuing a sale is often the most significant financial and strategic milestone of their careers. A successful transaction can unlock meaningful liquidity, establish long-term growth partnerships, and solidify the legacy of the business. Yet achieving the best possible outcome requires far more than simply finding a buyer. It […]